The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma
Wenying Shu(Guangzhou Medical University), Fanfan Zhou(The University of Sydney)
Cited by 8
Related Papers
No related papers found
Powered by citation graph analysis